Literature DB >> 29855966

Analysis of Protein-Protein Interaction by Co-IP in Human Cells.

Zhenyuan Tang1, Yoshinori Takahashi2.   

Abstract

While there are various approaches available to analyze protein-protein interactions, coimmunoprecipitation (co-IP) remains one of the most classic and commonly used methods to discover novel protein interactions or to determine the physical association of proteins. The assay begins with the preparation of total cell or tissue lysate in an appropriate lysis buffer. Protein of interest in the lysate is captured using a specific antibody and precipitated along with its binding proteins using a resin. After a series of washes to remove nonbound proteins in the lysate, the resultant immune complexes are subjected to immunoblotting, in-gel protein staining, or mass spectrometry to determine the protein-protein interaction of interest. In this chapter, a standard IP/co-IP protocol is described and potential problems and troubleshooting are discussed.

Entities:  

Keywords:  Antibody–protein; Coimmunoprecipitation; Immunoblotting; Mass spectrometry; Protein–protein interaction

Mesh:

Substances:

Year:  2018        PMID: 29855966     DOI: 10.1007/978-1-4939-7871-7_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Multiomics Approach Reveals an Important Role of BNIP3 in Myocardial Remodeling and the Pathogenesis of Heart Failure with Reduced Ejection Fraction.

Authors:  Antoine H Chaanine; LeeAnn Higgins; Lothar Lauterboeck; Todd Markowski; Qinglin Yang; Patrice Delafontaine
Journal:  Cells       Date:  2022-05-06       Impact factor: 7.666

2.  PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.

Authors:  Zhihong Lu; Xiujuan Zhu; Yuhong Ye; Haidong Fu; Jianhua Mao
Journal:  Cytotechnology       Date:  2021-08-13       Impact factor: 2.040

Review 3.  Visualization of in vivo protein-protein interactions in plants.

Authors:  Vivien I Strotmann; Yvonne Stahl
Journal:  J Exp Bot       Date:  2022-06-24       Impact factor: 7.298

Review 4.  Exploring Protein⁻Protein Interaction in the Study of Hormone-Dependent Cancers.

Authors:  Yasuhiro Miki; Erina Iwabuchi; Katsuhiko Ono; Hironobu Sasano; Kiyoshi Ito
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

5.  TOM40 Targets Atg2 to Mitochondria-Associated ER Membranes for Phagophore Expansion.

Authors:  Zhenyuan Tang; Yoshinori Takahashi; Haiyan He; Tatsuya Hattori; Chong Chen; Xinwen Liang; Han Chen; Megan M Young; Hong-Gang Wang
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

6.  Discovery of novel KRAS‒PDEδ inhibitors with potent activity in patient-derived human pancreatic tumor xenograft models.

Authors:  Long Chen; Jing Zhang; Xinjing Wang; Yu Li; Lu Zhou; Xiongxiong Lu; Guoqiang Dong; Chunquan Sheng
Journal:  Acta Pharm Sin B       Date:  2021-07-19       Impact factor: 11.413

7.  Benchmark Evaluation of Protein-Protein Interaction Prediction Algorithms.

Authors:  Brandan Dunham; Madhavi K Ganapathiraju
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.927

8.  ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1.

Authors:  Zhuo Shao; Chenggang Li; Qiao Wu; Xingmao Zhang; Yang Dai; Shenming Li; Xinyuan Liu; Xinying Zheng; Jiansheng Zhang; Hua Fan
Journal:  Oncogenesis       Date:  2022-08-04       Impact factor: 6.524

9.  Investigating the Effect of Tyrosine Kinase Inhibitors on the Interaction between Human Serum Albumin by Atomic Force Microscopy.

Authors:  Yuna Fu; Jianhua Wang; Yan Wang; Heng Sun
Journal:  Biomolecules       Date:  2022-06-11

Review 10.  The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination.

Authors:  Jinmei Jin; Ye Wu; Jinjiao Chen; Yiwen Shen; Lijun Zhang; Hong Zhang; Lili Chen; Hebao Yuan; Hongzhuan Chen; Weidong Zhang; Xin Luan
Journal:  Theranostics       Date:  2020-08-08       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.